21/05/2019 16:28:00

Issue of Equity

Finsbury Growth & Income Trust Plc - Issue of Equity

PR Newswire

FINSBURY GROWTH & INCOME TRUST PLC

Legal Entity Identifier:  213800NN4ZKX2LG1GQ40

Issue of Ordinary Shares

On 21 May 2019 FINSBURY GROWTH & INCOME TRUST PLC (the “Company”) issued from its block listing authority of 14 January 2019 60,000 new Ordinary shares of 25p each at a price of 897.75 pence per share; these shares rank pari passu with the existing Ordinary shares in issue. The issue price equates to a premium to the cum income net asset value per share at the time of the transaction of 0.7%, such premium including a placing commission of 0.2%.

Following this issue, the Company has the ability to issue a further 3,550,001 ordinary shares under its block listing facility.

As a result of this issue, the total number of ordinary shares in issue now stands at 193,966,712 and the total number of voting rights in the Company is 193,966,712 There are no shares held in treasury.

The above figure of 193,966,712 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

Enquiries:

Victoria Hale

Frostrow Capital LLP             

Tel: 0203 170 8732

Related content
14:40 - 
Net Asset Value(s)
14:14 - 
Issue of Equity
21 Jun - 
Net Asset Value(s)
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

14:40 E:FGT
14:14 E:FGT
21 Jun E:FGT
20 Jun E:FGT
19 Jun E:FGT
18 Jun E:FGT
17 Jun E:FGT
14 Jun E:FGT
13 Jun E:FGT

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
OSE Immunotherapeutics Will Participate in HealthTech Investor Days (HTID)
2
Global Arena Holding Inc. (GAHC), Files First Quarter 10Q, and Updates Shareholders on Subsidiaries
3
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Eros International Plc (NYSE: EROS) and Encourages Eros Investors to Contact the Firm
4
Hofseth Biocare ASA: Signed Letter of Intent with Garden of Life® for exclusive use of CollaGo® and ProGo® in the US market
5
Final Data Analysis of Phase 2 PBC Trial Shows that Genkyotex’s Anti-fibrotic Candidate GKT831 Demonstrated Statistically Significant Improvements in GGT and ALP Over Full Treatment Period

Related stock quotes

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
24 June 2019 23:33:13
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB1 - 2019-06-25 00:33:13 - 2019-06-24 23:33:13 - 1000 - Website: OKAY